Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine.
The global Gastrointestinal Stromal Tumors (GSTs) Treatment market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LPI (LP Information)' newest research report, the “Gastrointestinal Stromal Tumors (GSTs) Treatment Industry Forecast” looks at past sales and reviews total world Gastrointestinal Stromal Tumors (GSTs) Treatment sales in 2023, providing a comprehensive analysis by region and market sector of projected Gastrointestinal Stromal Tumors (GSTs) Treatment sales for 2024 through 2030. With Gastrointestinal Stromal Tumors (GSTs) Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastrointestinal Stromal Tumors (GSTs) Treatment industry.
This Insight Report provides a comprehensive analysis of the global Gastrointestinal Stromal Tumors (GSTs) Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gastrointestinal Stromal Tumors (GSTs) Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gastrointestinal Stromal Tumors (GSTs) Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastrointestinal Stromal Tumors (GSTs) Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastrointestinal Stromal Tumors (GSTs) Treatment.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Stromal Tumors (GSTs) Treatment market by product type, application, key players and key regions and countries.
Segmentation by type
A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine.
The global Gastrointestinal Stromal Tumors (GSTs) Treatment market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LPI (LP Information)' newest research report, the “Gastrointestinal Stromal Tumors (GSTs) Treatment Industry Forecast” looks at past sales and reviews total world Gastrointestinal Stromal Tumors (GSTs) Treatment sales in 2023, providing a comprehensive analysis by region and market sector of projected Gastrointestinal Stromal Tumors (GSTs) Treatment sales for 2024 through 2030. With Gastrointestinal Stromal Tumors (GSTs) Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastrointestinal Stromal Tumors (GSTs) Treatment industry.
This Insight Report provides a comprehensive analysis of the global Gastrointestinal Stromal Tumors (GSTs) Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gastrointestinal Stromal Tumors (GSTs) Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gastrointestinal Stromal Tumors (GSTs) Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastrointestinal Stromal Tumors (GSTs) Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastrointestinal Stromal Tumors (GSTs) Treatment.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Stromal Tumors (GSTs) Treatment market by product type, application, key players and key regions and countries.
Segmentation by type
- Surgery
- Targeted Therapy
- Radiation Therapy
- ChemOthersapy
- Others
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Bayer
- Novartis
- Immunicum
- Roche
- AB Science
- Arog Pharmaceuticals
- Boston Biomedical
- Sun Pharmaceutical
- Natco Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2019-2030
2.1.2 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Gastrointestinal Stromal Tumors (GSTs) Treatment Segment by Type
2.2.1 Surgery
2.2.2 Targeted Therapy
2.2.3 Radiation Therapy
2.2.4 ChemOthersapy
2.2.5 Others
2.3 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type
2.3.1 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2019-2024)
2.4 Gastrointestinal Stromal Tumors (GSTs) Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Centers
2.4.4 Others
2.5 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application
2.5.1 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2019-2024)
3 GASTROINTESTINAL STROMAL TUMORS (GSTS) TREATMENT MARKET SIZE BY PLAYER
3.1 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Players
3.1.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue by Players (2019-2024)
3.1.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL STROMAL TUMORS (GSTS) TREATMENT BY REGIONS
4.1 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Regions (2019-2024)
4.2 Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth (2019-2024)
4.3 APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth (2019-2024)
4.4 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2019-2024)
5.2 Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2019-2024)
5.3 Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region (2019-2024)
6.2 APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2019-2024)
6.3 APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment by Country (2019-2024)
7.2 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2019-2024)
7.3 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment by Region (2019-2024)
8.2 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GASTROINTESTINAL STROMAL TUMORS (GSTS) TREATMENT MARKET FORECAST
10.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast by Regions (2025-2030)
10.1.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast
10.1.3 APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast
10.1.4 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast
10.1.5 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast
10.2 Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast by Country (2025-2030)
10.2.1 United States Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.2.2 Canada Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.2.3 Mexico Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.2.4 Brazil Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.3 APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast by Region (2025-2030)
10.3.1 China Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.3.2 Japan Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.3.3 Korea Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.3.4 Southeast Asia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.3.5 India Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.3.6 Australia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.4 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast by Country (2025-2030)
10.4.1 Germany Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.4.2 France Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.4.3 UK Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.4.4 Italy Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.4.5 Russia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.5 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.5.2 South Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.5.3 Israel Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.5.4 Turkey Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.5.5 GCC Countries Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.6 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast by Type (2025-2030)
10.7 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.1.3 Pfizer Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.2.3 Bayer Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bayer Main Business Overview
11.2.5 Bayer Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.3.3 Novartis Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Immunicum
11.4.1 Immunicum Company Information
11.4.2 Immunicum Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.4.3 Immunicum Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Immunicum Main Business Overview
11.4.5 Immunicum Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.5.3 Roche Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 AB Science
11.6.1 AB Science Company Information
11.6.2 AB Science Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.6.3 AB Science Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AB Science Main Business Overview
11.6.5 AB Science Latest Developments
11.7 Arog Pharmaceuticals
11.7.1 Arog Pharmaceuticals Company Information
11.7.2 Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.7.3 Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Arog Pharmaceuticals Main Business Overview
11.7.5 Arog Pharmaceuticals Latest Developments
11.8 Boston Biomedical
11.8.1 Boston Biomedical Company Information
11.8.2 Boston Biomedical Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.8.3 Boston Biomedical Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Boston Biomedical Main Business Overview
11.8.5 Boston Biomedical Latest Developments
11.9 Sun Pharmaceutical
11.9.1 Sun Pharmaceutical Company Information
11.9.2 Sun Pharmaceutical Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.9.3 Sun Pharmaceutical Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sun Pharmaceutical Main Business Overview
11.9.5 Sun Pharmaceutical Latest Developments
11.10 Natco Pharma
11.10.1 Natco Pharma Company Information
11.10.2 Natco Pharma Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.10.3 Natco Pharma Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Natco Pharma Main Business Overview
11.10.5 Natco Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2019-2030
2.1.2 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Gastrointestinal Stromal Tumors (GSTs) Treatment Segment by Type
2.2.1 Surgery
2.2.2 Targeted Therapy
2.2.3 Radiation Therapy
2.2.4 ChemOthersapy
2.2.5 Others
2.3 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type
2.3.1 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2019-2024)
2.4 Gastrointestinal Stromal Tumors (GSTs) Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Centers
2.4.4 Others
2.5 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application
2.5.1 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2019-2024)
3 GASTROINTESTINAL STROMAL TUMORS (GSTS) TREATMENT MARKET SIZE BY PLAYER
3.1 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Players
3.1.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue by Players (2019-2024)
3.1.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL STROMAL TUMORS (GSTS) TREATMENT BY REGIONS
4.1 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Regions (2019-2024)
4.2 Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth (2019-2024)
4.3 APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth (2019-2024)
4.4 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2019-2024)
5.2 Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2019-2024)
5.3 Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region (2019-2024)
6.2 APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2019-2024)
6.3 APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment by Country (2019-2024)
7.2 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2019-2024)
7.3 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment by Region (2019-2024)
8.2 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GASTROINTESTINAL STROMAL TUMORS (GSTS) TREATMENT MARKET FORECAST
10.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast by Regions (2025-2030)
10.1.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast
10.1.3 APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast
10.1.4 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast
10.1.5 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast
10.2 Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast by Country (2025-2030)
10.2.1 United States Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.2.2 Canada Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.2.3 Mexico Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.2.4 Brazil Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.3 APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast by Region (2025-2030)
10.3.1 China Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.3.2 Japan Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.3.3 Korea Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.3.4 Southeast Asia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.3.5 India Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.3.6 Australia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.4 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast by Country (2025-2030)
10.4.1 Germany Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.4.2 France Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.4.3 UK Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.4.4 Italy Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.4.5 Russia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.5 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.5.2 South Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.5.3 Israel Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.5.4 Turkey Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.5.5 GCC Countries Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast
10.6 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast by Type (2025-2030)
10.7 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.1.3 Pfizer Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.2.3 Bayer Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bayer Main Business Overview
11.2.5 Bayer Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.3.3 Novartis Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Immunicum
11.4.1 Immunicum Company Information
11.4.2 Immunicum Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.4.3 Immunicum Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Immunicum Main Business Overview
11.4.5 Immunicum Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.5.3 Roche Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 AB Science
11.6.1 AB Science Company Information
11.6.2 AB Science Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.6.3 AB Science Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AB Science Main Business Overview
11.6.5 AB Science Latest Developments
11.7 Arog Pharmaceuticals
11.7.1 Arog Pharmaceuticals Company Information
11.7.2 Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.7.3 Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Arog Pharmaceuticals Main Business Overview
11.7.5 Arog Pharmaceuticals Latest Developments
11.8 Boston Biomedical
11.8.1 Boston Biomedical Company Information
11.8.2 Boston Biomedical Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.8.3 Boston Biomedical Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Boston Biomedical Main Business Overview
11.8.5 Boston Biomedical Latest Developments
11.9 Sun Pharmaceutical
11.9.1 Sun Pharmaceutical Company Information
11.9.2 Sun Pharmaceutical Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.9.3 Sun Pharmaceutical Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sun Pharmaceutical Main Business Overview
11.9.5 Sun Pharmaceutical Latest Developments
11.10 Natco Pharma
11.10.1 Natco Pharma Company Information
11.10.2 Natco Pharma Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
11.10.3 Natco Pharma Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Natco Pharma Main Business Overview
11.10.5 Natco Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Surgery
Table 3. Major Players of Targeted Therapy
Table 4. Major Players of Radiation Therapy
Table 5. Major Players of ChemOthersapy
Table 6. Major Players of Others
Table 7. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2019-2024)
Table 10. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2019-2024)
Table 13. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Market Share by Player (2019-2024)
Table 15. Gastrointestinal Stromal Tumors (GSTs) Treatment Key Players Head office and Products Offered
Table 16. Gastrointestinal Stromal Tumors (GSTs) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Regions (2019-2024)
Table 21. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Country (2019-2024)
Table 25. Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2019-2024)
Table 27. Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2019-2024)
Table 29. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Region (2019-2024)
Table 31. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2019-2024)
Table 33. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2019-2024)
Table 35. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Country (2019-2024)
Table 37. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2019-2024)
Table 39. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Gastrointestinal Stromal Tumors (GSTs) Treatment
Table 48. Key Market Challenges & Risks of Gastrointestinal Stromal Tumors (GSTs) Treatment
Table 49. Key Industry Trends of Gastrointestinal Stromal Tumors (GSTs) Treatment
Table 50. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Pfizer Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 55. Pfizer Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 56. Pfizer Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Pfizer Main Business
Table 58. Pfizer Latest Developments
Table 59. Bayer Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 60. Bayer Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 61. Bayer Main Business
Table 62. Bayer Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Bayer Latest Developments
Table 64. Novartis Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 65. Novartis Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 66. Novartis Main Business
Table 67. Novartis Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Novartis Latest Developments
Table 69. Immunicum Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 70. Immunicum Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 71. Immunicum Main Business
Table 72. Immunicum Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Immunicum Latest Developments
Table 74. Roche Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 75. Roche Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 76. Roche Main Business
Table 77. Roche Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Roche Latest Developments
Table 79. AB Science Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 80. AB Science Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 81. AB Science Main Business
Table 82. AB Science Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. AB Science Latest Developments
Table 84. Arog Pharmaceuticals Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 85. Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 86. Arog Pharmaceuticals Main Business
Table 87. Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Arog Pharmaceuticals Latest Developments
Table 89. Boston Biomedical Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 90. Boston Biomedical Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 91. Boston Biomedical Main Business
Table 92. Boston Biomedical Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Boston Biomedical Latest Developments
Table 94. Sun Pharmaceutical Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 95. Sun Pharmaceutical Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 96. Sun Pharmaceutical Main Business
Table 97. Sun Pharmaceutical Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Sun Pharmaceutical Latest Developments
Table 99. Natco Pharma Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 100. Natco Pharma Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 101. Natco Pharma Main Business
Table 102. Natco Pharma Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Natco Pharma Latest Developments
Table 1. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Surgery
Table 3. Major Players of Targeted Therapy
Table 4. Major Players of Radiation Therapy
Table 5. Major Players of ChemOthersapy
Table 6. Major Players of Others
Table 7. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2019-2024)
Table 10. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2019-2024)
Table 13. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Market Share by Player (2019-2024)
Table 15. Gastrointestinal Stromal Tumors (GSTs) Treatment Key Players Head office and Products Offered
Table 16. Gastrointestinal Stromal Tumors (GSTs) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Regions (2019-2024)
Table 21. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Country (2019-2024)
Table 25. Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2019-2024)
Table 27. Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2019-2024)
Table 29. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Region (2019-2024)
Table 31. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2019-2024)
Table 33. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2019-2024)
Table 35. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Country (2019-2024)
Table 37. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2019-2024)
Table 39. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Gastrointestinal Stromal Tumors (GSTs) Treatment
Table 48. Key Market Challenges & Risks of Gastrointestinal Stromal Tumors (GSTs) Treatment
Table 49. Key Industry Trends of Gastrointestinal Stromal Tumors (GSTs) Treatment
Table 50. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Pfizer Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 55. Pfizer Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 56. Pfizer Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Pfizer Main Business
Table 58. Pfizer Latest Developments
Table 59. Bayer Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 60. Bayer Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 61. Bayer Main Business
Table 62. Bayer Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Bayer Latest Developments
Table 64. Novartis Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 65. Novartis Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 66. Novartis Main Business
Table 67. Novartis Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Novartis Latest Developments
Table 69. Immunicum Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 70. Immunicum Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 71. Immunicum Main Business
Table 72. Immunicum Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Immunicum Latest Developments
Table 74. Roche Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 75. Roche Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 76. Roche Main Business
Table 77. Roche Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Roche Latest Developments
Table 79. AB Science Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 80. AB Science Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 81. AB Science Main Business
Table 82. AB Science Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. AB Science Latest Developments
Table 84. Arog Pharmaceuticals Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 85. Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 86. Arog Pharmaceuticals Main Business
Table 87. Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Arog Pharmaceuticals Latest Developments
Table 89. Boston Biomedical Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 90. Boston Biomedical Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 91. Boston Biomedical Main Business
Table 92. Boston Biomedical Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Boston Biomedical Latest Developments
Table 94. Sun Pharmaceutical Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 95. Sun Pharmaceutical Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 96. Sun Pharmaceutical Main Business
Table 97. Sun Pharmaceutical Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Sun Pharmaceutical Latest Developments
Table 99. Natco Pharma Details, Company Type, Gastrointestinal Stromal Tumors (GSTs) Treatment Area Served and Its Competitors
Table 100. Natco Pharma Gastrointestinal Stromal Tumors (GSTs) Treatment Product Offered
Table 101. Natco Pharma Main Business
Table 102. Natco Pharma Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Natco Pharma Latest Developments
LIST OF FIGURES
Figure 1. Gastrointestinal Stromal Tumors (GSTs) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Gastrointestinal Stromal Tumors (GSTs) Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Gastrointestinal Stromal Tumors (GSTs) Treatment Sales Market Share by Country/Region (2023)
Figure 8. Gastrointestinal Stromal Tumors (GSTs) Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type in 2023
Figure 10. Gastrointestinal Stromal Tumors (GSTs) Treatment in Hospitals
Figure 11. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Gastrointestinal Stromal Tumors (GSTs) Treatment in Clinics
Figure 13. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Gastrointestinal Stromal Tumors (GSTs) Treatment in Ambulatory Surgical Centers
Figure 15. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market: Ambulatory Surgical Centers (2019-2024) & ($ Millions)
Figure 16. Gastrointestinal Stromal Tumors (GSTs) Treatment in Others
Figure 17. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application in 2023
Figure 19. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Market Share by Player in 2023
Figure 20. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2019-2024 ($ Millions)
Figure 22. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2019-2024 ($ Millions)
Figure 23. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2019-2024 ($ Millions)
Figure 25. Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Value Market Share by Country in 2023
Figure 26. United States Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Region in 2023
Figure 31. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type in 2023
Figure 32. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application in 2023
Figure 33. China Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Country in 2023
Figure 40. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2019-2024)
Figure 41. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2019-2024)
Figure 42. Germany Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 56. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 57. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 59. United States Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 60. Canada Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 63. China Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 64. Japan Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 65. Korea Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 67. India Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 68. Australia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 69. Germany Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 70. France Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 71. UK Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 72. Italy Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 73. Russia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 74. Spain Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 77. Israel Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 80. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Gastrointestinal Stromal Tumors (GSTs) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Gastrointestinal Stromal Tumors (GSTs) Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Gastrointestinal Stromal Tumors (GSTs) Treatment Sales Market Share by Country/Region (2023)
Figure 8. Gastrointestinal Stromal Tumors (GSTs) Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type in 2023
Figure 10. Gastrointestinal Stromal Tumors (GSTs) Treatment in Hospitals
Figure 11. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Gastrointestinal Stromal Tumors (GSTs) Treatment in Clinics
Figure 13. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Gastrointestinal Stromal Tumors (GSTs) Treatment in Ambulatory Surgical Centers
Figure 15. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market: Ambulatory Surgical Centers (2019-2024) & ($ Millions)
Figure 16. Gastrointestinal Stromal Tumors (GSTs) Treatment in Others
Figure 17. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application in 2023
Figure 19. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Market Share by Player in 2023
Figure 20. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2019-2024 ($ Millions)
Figure 22. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2019-2024 ($ Millions)
Figure 23. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2019-2024 ($ Millions)
Figure 25. Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Value Market Share by Country in 2023
Figure 26. United States Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Region in 2023
Figure 31. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type in 2023
Figure 32. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application in 2023
Figure 33. China Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Country in 2023
Figure 40. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2019-2024)
Figure 41. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2019-2024)
Figure 42. Germany Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 56. APAC Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 57. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 59. United States Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 60. Canada Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 63. China Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 64. Japan Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 65. Korea Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 67. India Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 68. Australia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 69. Germany Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 70. France Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 71. UK Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 72. Italy Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 73. Russia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 74. Spain Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 77. Israel Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size 2025-2030 ($ Millions)
Figure 80. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share Forecast by Application (2025-2030)
